Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Crown Records Management
Crown Records Management
Activities:
Patient Experience
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
N4 Pharma and SRI to target and treat previously unreachable human cells
The companies will collaborate to perform research to conjugate SRI’s MGS system to Nuvec to increase intracellular delivery to specific target cells.
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Regulatory
Healthcare professionals express opinions on personal data
Professionals in the healthcare sector want their personal data edited or deleted when GDPR comes in
Digital
Data management in the future
Pharma leads the way in long-term digital preservation as the battle hots up to keep data readable in future
Digital
Ten ways to shine a light on dark data in pharmaceuticals and find value in it
How businesses can benefit from finally taking control of the great unknown
Regulatory
Pharma sector praised for bringing data protection reforms despite Brexit
Half of companies see Brexit as an opportunity for Britain to position itself as the safest place to do business
Regulatory
Why pharmaceutical companies should still prepare for EU General Data Protection Regulation in the new year – regardless of Brexit
Don’t give up on data reforms just because UK is quitting Europe
Subscribe now